What does DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE do?

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is a healthcare practice in Pajottegem. Private Limited, started on 29 December 1989, 1 establishment.

What is the address of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

The registered office of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is located at Dorpsstraat 58, 1755 Pajottegem.

Is DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE still active?

Yes. According to the CBE (31 October 2026) DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is active, legal situation “Normale toestand”, started on 29 December 1989.

Is DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE registered on Peppol?

Yes, DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is registered on the Peppol network with ID 0208:0439896582.

What is the enterprise number of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

The enterprise number of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is BE0439896582.

When was DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE founded?

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE was founded on 29 December 1989.

Who are the directors of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

According to the 2025 annual accounts, the directors of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE are: Pierre Agneessens, Veronique Driegelinck.

Is DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 29 December 1989; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE make in 2025?

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE posted a profit after taxes of € 84,524 in financial year 2025.

What is the revenue of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

As a small company, DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 159,279.

Does DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE have a website?

Yes, DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE has a website at dokterpierreagneessens.be.

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE (Private Limited)

Dossier DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE, printed on 1 November 2026 from databakkes.be/en/0439896582/dr-pierre-agneessens-algemene-geneeskunde. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE from Pajottegem, company number BE0439896582, closed financial year 2025 with a result of € 84,524 after tax. For that financial year DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE recorded a gross margin of € 159,279 and equity of € 587,355. Compared with financial year 2024, the result moved from € 70,463 to € 84,524. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.

What it is worth Growing

€ 587,355

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 84,524

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 41,624

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 65,229 paid out

77 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,258

▼ 79% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 112

▼ 65% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,535

▼ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 112,822 Gross margin 2022: € 112,822 First fiscal year in the series	€ 74,495 Gross margin 2023: € 74,495 ▼ 34% vs 2022 (€ 112,822) Unfavourable step	€ 155,214 Gross margin 2024: € 155,214 ▲ 108% vs 2023 (€ 74,495) Favourable step	€ 159,279 Gross margin 2025: € 159,279 ▲ 3% vs 2024 (€ 155,214) Favourable step	▲ 3%
Profit after taxes	€ 46,232 Profit after taxes 2022: € 46,232 First fiscal year in the series	€ 17,475 Profit after taxes 2023: € 17,475 ▼ 62% vs 2022 (€ 46,232) Unfavourable step	€ 70,463 Profit after taxes 2024: € 70,463 ▲ € 52,988 vs 2023 (€ 17,475) Favourable step	€ 84,524 Profit after taxes 2025: € 84,524 ▲ 20% vs 2024 (€ 70,463) Favourable step	▲ 20%
Equity	€ 514,812 Equity 2022: € 514,812 First fiscal year in the series	€ 511,095 Equity 2023: € 511,095 ▼ 1% vs 2022 (€ 514,812) Unfavourable step	€ 568,060 Equity 2024: € 568,060 ▲ 11% vs 2023 (€ 511,095) Favourable step	€ 587,355 Equity 2025: € 587,355 ▲ 3% vs 2024 (€ 568,060) Favourable step	▲ 3%
Total debts	€ 190,949 Total debts 2022: € 190,949 First fiscal year in the series	€ 28,534 Total debts 2023: € 28,534 ▼ 85% vs 2022 (€ 190,949) Favourable step	€ 52,569 Total debts 2024: € 52,569 ▲ 84% vs 2023 (€ 28,534) Unfavourable step	€ 46,397 Total debts 2025: € 46,397 ▼ 12% vs 2024 (€ 52,569) Favourable step	▼ 12%
Cash	€ 191,843 Cash 2022: € 191,843 First fiscal year in the series	€ 75,995 Cash 2023: € 75,995 ▼ 60% vs 2022 (€ 191,843) Unfavourable step	€ 56,678 Cash 2024: € 56,678 ▼ 25% vs 2023 (€ 75,995) Unfavourable step	€ 41,624 Cash 2025: € 41,624 ▼ 27% vs 2024 (€ 56,678) Unfavourable step	▼ 27%
Land & buildings	€ 434,472 Land & buildings 2022: € 434,472 First fiscal year in the series	€ 413,588 Land & buildings 2023: € 413,588 ▼ 5% vs 2022 (€ 434,472) Unchanged	€ 396,053 Land & buildings 2024: € 396,053 ▼ 4% vs 2023 (€ 413,588) Unchanged	€ 373,457 Land & buildings 2025: € 373,457 ▼ 6% vs 2024 (€ 396,053) Unchanged	▼ 6%
Retained profit	€ 419,474 Retained profit 2022: € 419,474 First fiscal year in the series	€ 415,757 Retained profit 2023: € 415,757 ▼ 1% vs 2022 (€ 419,474) Unfavourable step	€ 472,722 Retained profit 2024: € 472,722 ▲ 14% vs 2023 (€ 415,757) Favourable step	€ 492,017 Retained profit 2025: € 492,017 ▲ 4% vs 2024 (€ 472,722) Favourable step	▲ 4%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 21,191 Dividend 2023: € 21,191 Unchanged (€ 0) Unchanged	€ 13,498 Dividend 2024: € 13,498 ▼ 36% vs 2023 (€ 21,191) Unchanged	€ 65,229 Dividend 2025: € 65,229 ▲ € 51,731 vs 2024 (€ 13,498) Unchanged	▲ € 51,731
Balance sheet total	€ 705,760 Balance sheet total 2022: € 705,760 First fiscal year in the series	€ 539,629 Balance sheet total 2023: € 539,629 ▼ 24% vs 2022 (€ 705,760) Unchanged	€ 620,629 Balance sheet total 2024: € 620,629 ▲ 15% vs 2023 (€ 539,629) Unchanged	€ 633,752 Balance sheet total 2025: € 633,752 ▲ 2% vs 2024 (€ 620,629) Unchanged	▲ 2%

Key figures of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

What happened at DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

May 27, 2026 New annual accounts for financial year 2025: profit of € 84,524 (▲ 20% vs 2024). Source: NBB ↗
2023 Veronique Driegelinck became a director. NBB
2023 Pierre Agneessens became a director. NBB
Jan 31, 1990 New establishment in Pajottegem. KBO
Dec 29, 1989 Start of the company according to the CBE. KBO

In short

From € 46,232 profit in 2022 to € 84,524 profit in 2025.

Paid € 94,398 in corporate taxes since 2022.

Best year ever: 2025, with € 84,524 profit.

Paid out € 99,918 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Pierre Agneessens Veronique Driegelinck

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE

Behind DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE are Pierre Agneessens and Veronique Driegelinck.

Directors

According to the 2025 annual accounts

Pierre Agneessens

Director

since 2023

Veronique Driegelinck

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 58

1755 Pajottegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS dokterpierreagneessens.be

Canonical: https://www.dokterpierreagneessens.be/

Technologies

Amazon CloudFrontGoogle FontsGoogle Tag Manager

Certifications & Partners

FEB/VBO

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-02 - Amazon.com, Inc., US

Website info

HTTPS Ja

Indexable pages 5

Languages NL

Features

Webshop Ads Contact page

Security

✓ HTTPS

✓ SPF

✗ DMARC

Network

✓ Load balancing

Details

Company number

0439.896.582

VAT number

BE 0439.896.582

Registered office

Dorpsstraat 58, 1755 Pajottegem

Names & denominations

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

29 December 1989

Peppol

Active · Active since 27 Nov 2024

Contact

dokterpierreagneessens.be

Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

View on CBE Public ↗ Annual accounts (NBB) ↗

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE

Financials

What happened to DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

Management

Directors

Establishments

Establishment units

Website

Technologies

Certifications & Partners

Hosting & Email

Website info

Features

Security

Network

Details

Frequently asked questions